Dermatomyositis

British Journal of Hospital Medicine

Volumn 73, Issue SUPPL. 2, 2012, Pages

  Mahil, Satveer ^a   Marks, Daniel ^a   McCormack, Mary ^a   Rahman, Anisur ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; IMMUNOSUPPRESSIVE AGENT;

BLOOD; DERMATOMYOSITIS; HUMAN; MONITORING; NEOPLASM; PATHOPHYSIOLOGY; PROGNOSIS; REVIEW;

AUTOANTIBODIES; DERMATOMYOSITIS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MONITORING, PHYSIOLOGIC; NEOPLASMS; PROGNOSIS;

EID: 84861149637     PISSN: 17508460     EISSN: None     Source Type: Journal    
DOI: 10.12968/hmed.2012.73.Sup2.C18     Document Type: Article

References (31)

1. Andras C, Ponyi A, Constantin T et al (2008) Dermatomyositis and polymyositis associated with malignancy: A 21-year retrospective study. J Rheumatol 35: 438-44 (Pubitemid 351374417)
2. Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (Parts 1 and 2) N Engl J Med 292: 344-7, 403-7
3. Callen JP (2000) Dermatomyositis. Lancet 355: 53-7 (Pubitemid 30072189)
4. Callen JP (2002) When and how should the patient with dermatomyositis or amyopathic dermatomyositis be assessed for possible cancer? Arch Dernatol 138: 969-70
5. Callen JP, Wortmann RL (2006) Dermatomyositis. Clin Dermatol 24: 363-73 (Pubitemid 44332867)
6. Choy EHS, Isenberg DA (2002) Treatment of dermatomyositis and polymyositis. Rheumatology 41: 7-13 (Pubitemid 34537914)
7. Cordeiro AC, Isenberg DA (2006) Treatment of inflammatory myopathies. Postgrad Med J 82: 417-24 (Pubitemid 44076302)
8. Dalakas MC (2002) Muscle biopsy findings in inflammatory myopathies. Rheum Dis Clin N Am 28: 779-98 (Pubitemid 36008552)
9. Dalakas MC (2010) Immunotherapy of myositis: issues, concerns and future prospects. Nat Rev Rheumatol 6: 129-37
10. Dalakas MC, Hohlfeld R (2003) Polymyositis and dermatomyositis. Lancet 362: 971-82 (Pubitemid 37159295)
11. Dalakas MC, Illa I, Dambrosia JM et al (1993) A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis. N Engl J Med 329: 1993-2000 (Pubitemid 24015043)
12. Ebert EC (2009) Review article: the gastrointestinal complications of myositis. Aliment Pharmacol Ther 31: 359-65
13. Emslie-Smith AM, Engel AG (1990) Miscrovascular changes in early and advanced dermatomyositis: a quantitative study. Ann Neurol 27: 343-56 (Pubitemid 20132049)
14. Euwer RL, Sontheimer RD (1991) Amyopathic DM (DM sine myositis). J Am Acad Dermatol 24: 959-66
15. Fathi M, Lundberg IE (2005) Interstitial lung disease in polymyositis and dermatomyositis. Curr Opin Rheumatol 17: 701-6 (Pubitemid 41546487)
16. Feldman BM, Rider LG, Reed AM, Pachman LM (2008) Juvenile dermatomyositis and other idiopathic inflammatory myopathies of childhood. Lancet 371: 2201-12 (Pubitemid 351890413)
17. Fudman EJ, Schnitzer TJ (1986) Dermatomyositis without creatine kinase elevation: poor prognostic sign. Am J Med 80: 329-32 (Pubitemid 16140792)
18. Garcia J (2000) MRI in inflammatory myopathies. Skeletal Radiol 29: 425-38 (Pubitemid 30662259)
19. Gunawardena H, Betteridge ZE, McHugh NJ (2009) Myositis-specific autoantibodies: their clinical and pathogenic significance in disease expression. Rheumatology 48: 607-12
20. Hengstman G, Van der Hoogan F, Barrera P et al (2003) Successful treament of dermatomyositis and polymyositis with anti-tumor-necrosis-factor-alpha: preliminary observations. Eur Neurol 50: 10-15 (Pubitemid 36736963)
21. Hill CL, Zhang Y, Sigurgeirsson B et al (2001) Frequency of specific cancer types in dermatomyositis and polymyositis: a populationbased study. Lancet 357: 96-100 (Pubitemid 32094911)
22. Hunger RE, Durr D, Brand CU (2001) Cutaneous vasculitis in dermatomyositis suggests malignancy. Dermatology 202: 123-6 (Pubitemid 32337162)
23. Levine T (2005) Rituximab in the treatment of dermatomyositis- an open label pilot study. Arthritis Rheum 52: 601-7 (Pubitemid 40216325)
24. Love LA, Leff RL, Fraser DD et al (1991) A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient group. Medicine 70: 360-74
25. Lundberg IE (2006) The heart in dermatomyositis and polymyositis. Rheumatology 45: 18-21
26. Osako T, Ito Y, Morimatsu A et al (2007) Flare-up of dermatomyositis along with recurrence of breast cancer. Breast J 13: 200-2 (Pubitemid 46280610)
27. Peng J-C, Sheen T-S, Hsu M-M (1995) Nasopharyngeal carcinoma with dermatomyositis: analysis of 12 cases. Arch Otolaryngol Head and Neck Surg 121: 1298-301
28. Sayers ME, Chou SM, Calabrese LH (1992) Inclusion body myositis: analysis of 32 cases. J Rheumatol 19: 1385-9
29. Siguregeirsson B, Lindekof B, Edhag O, Allander E (1992) Risk of cancer in patients with dermatomyositis or polymyositis. N Engl J Med 325: 363-7
30. Sparsa A, Liozon E, Herrmann F et al (2002) Routine vs extensive malignancy search for adult dermatomyositis and polymyositis. Arch Dermatol 138: 885-90 (Pubitemid 34700734)
31. Targoff IN, Johnson AE, Miller FW (1990) Antibody to signal recognition particle in polymyositis. Arthritis Rheum 33: 1361-79